Skincare company BeautyHealth (NASDAQ:SKIN) will be announcing earnings results this Thursday after the bell. Here’s what to look for.
BeautyHealth beat analysts’ revenue expectations by 8.9% last quarter, reporting revenues of $69.58 million, down 14.5% year on year. It was a very strong quarter for the company, with an impressive beat of analysts’ gross margin estimates and a solid beat of analysts’ EBITDA estimates.
Is BeautyHealth a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting BeautyHealth’s revenue to decline 17.5% year on year to $74.74 million, improving from the 22.9% decrease it recorded in the same quarter last year. Adjusted loss is expected to come in at -$0.02 per share.
The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. BeautyHealth has missed Wall Street’s revenue estimates twice over the last two years.
Looking at BeautyHealth’s peers in the personal care segment, some have already reported their Q2 results, giving us a hint as to what we can expect. USANA delivered year-on-year revenue growth of 10.8%, beating analysts’ expectations by 4.7%, and Nature's Sunshine reported revenues up 3.8%, topping estimates by 2.2%. USANA traded up 12.4% following the results while Nature's Sunshine was also up 13.7%.
Read our full analysis of USANA’s results here and Nature's Sunshine’s results here.
Investors in the personal care segment have had fairly steady hands going into earnings, with share prices down 1.9% on average over the last month. BeautyHealth is down 25.9% during the same time and is heading into earnings with an average analyst price target of $1.66 (compared to the current share price of $1.63).
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.